Log in to save to my catalogue

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_beb4df350c934319b12d478d400b2afd

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes

About this item

Full title

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2023-02, Vol.10 (1), p.552-567

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute treatment effects.
Methods and results
Individual patient time‐to...

Alternative Titles

Full title

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_beb4df350c934319b12d478d400b2afd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_beb4df350c934319b12d478d400b2afd

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.14213

How to access this item